---
title: "Oruka Therapeutics (ORKA) surges 11% on analyst upgrade"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293063288.md"
description: "Oruka Therapeutics (ORKA.US) surges 11% to $91.76 on analyst upgrade citing healthcare upside potential."
datetime: "2026-07-17T17:33:46.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293063288.md)
  - [en](https://longbridge.com/en/news/293063288.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293063288.md)
generator: "portal-rs"
---

# Oruka Therapeutics (ORKA) surges 11% on analyst upgrade

Oruka Therapeutics(ORKA.US) 盘中涨**10.5%**，现报**91.76 美元**。

分析师上调该股评级，指出其作为医疗保健股票在 2026 年 7 月具有强劲上涨潜力。此前该股在常规交易中已上涨 8% 至 89.94 美元。

### Related Stocks

- [ORKA.US](https://longbridge.com/en/quote/ORKA.US.md)

## Related News & Research

- [Is Oruka Therapeutics (ORKA) Fully Valued As Psoriasis Pipeline Hopes Face A Pullback?](https://longbridge.com/en/news/298839254.md)
- [278,164 Shares in Oruka Therapeutics, Inc. $ORKA Acquired by Braidwell LP](https://longbridge.com/en/news/297882643.md)
- [Oruka Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update | ORKA Stock News](https://longbridge.com/en/news/295399117.md)
- [Oruka Therapeutics reports Q2 2026 results: $1.1B cash; net loss $41.2M in quarter](https://longbridge.com/en/news/295396150.md)
- [Oruka Therapeutics CMO Joana Goncalves disposes of 7,000 common shares for $601,227.73](https://longbridge.com/en/news/292825802.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**